- Home
- CRGX vs LVRO Comparison
CRGX vs LVRO Comparison
Compare CRGX & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- LVRO
- Stock Information
- Founded
- CRGX 2021
- LVRO 2017
- Country
- CRGX United States
- LVRO Brazil
- Employees
- CRGX N/A
- LVRO N/A
- Industry
- CRGX
- LVRO Blank Checks
- Sector
- CRGX
- LVRO Finance
- Exchange
- CRGX Nasdaq
- LVRO Nasdaq
- Market Cap
- CRGX 190.0M
- LVRO 279.6M
- IPO Year
- CRGX 2023
- LVRO N/A
- Fundamental
- Price
- CRGX $4.46
- LVRO $2.24
- Analyst Decision
- CRGX Hold
- LVRO Sell
- Analyst Count
- CRGX 7
- LVRO 3
- Target Price
- CRGX $4.67
- LVRO $1.88
- AVG Volume (30 Days)
- CRGX 502.9K
- LVRO 8.8K
- Earning Date
- CRGX 08-11-2025
- LVRO 07-11-2025
- Dividend Yield
- CRGX N/A
- LVRO N/A
- EPS Growth
- CRGX N/A
- LVRO N/A
- EPS
- CRGX N/A
- LVRO N/A
- Revenue
- CRGX N/A
- LVRO $1,667,345,189.00
- Revenue This Year
- CRGX $57.81
- LVRO N/A
- Revenue Next Year
- CRGX N/A
- LVRO $12.46
- P/E Ratio
- CRGX N/A
- LVRO N/A
- Revenue Growth
- CRGX N/A
- LVRO N/A
- 52 Week Low
- CRGX $3.00
- LVRO $1.90
- 52 Week High
- CRGX $25.45
- LVRO $5.69
- Technical
- Relative Strength Index (RSI)
- CRGX 57.89
- LVRO 39.14
- Support Level
- CRGX $4.09
- LVRO $1.95
- Resistance Level
- CRGX $4.51
- LVRO $2.22
- Average True Range (ATR)
- CRGX 0.18
- LVRO 0.20
- MACD
- CRGX 0.00
- LVRO -0.02
- Stochastic Oscillator
- CRGX 77.18
- LVRO 13.75
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.